The European Cooperative Study Group trial of intravenous recombinant tissue-type plasminogen activator (rt-PA) and conservative therapy versus rt-PA and immediate coronary angioplasty

This publication has 11 references indexed in Scilit:

• THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY
  The Lancet, 1988
• Percutaneous transluminal coronary angioplasty after thrombolytic therapy: A prospective controlled randomized trial
  Journal of the American College of Cardiology, 1986
• Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction
  Journal of the American College of Cardiology, 1986
• Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.
  Circulation, 1986
• DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.
  Circulation, 1984
• Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum α-hydroxybutyrate dehydrogenase levels
  American Heart Journal, 1984
• Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study.
  Heart, 1983